Literature DB >> 32902728

Informative value of histological assessment of tissue acquired during aquablation of the prostate.

Gautier Müllhaupt1, Annette Enzler-Tschudy2, Katarina Horg2, Lukas Bubendorf3, Manolis Pratsinis4, Hans-Peter Schmid4, Dominik Abt4.   

Abstract

PURPOSE: To determine the histological validity of the tissue acquired during aquablation of the prostate. PATIENTS AND METHODS: Prostatic tissue of 12 patients that consecutively underwent aquablation for benign prostatic enlargement was systematically examined. Histological examination was performed by two experienced uropathologists using a digital slide scanner and slide viewer software (Pannoramic 250 and Case Viewer 2.3, 3D Histech, Hungary). The surface areas of the assessable glands were examined and set in relation to the total surface area of the material available for histology and to the patient's total prostate volume. Examinations were performed analogously in ten consecutive patients undergoing transurethral resection of the prostate (TURP) to facilitate interpretation of the results. Data were analyzed using descriptive statistics.
RESULTS: A median of 4.06% (range 1.43-7.5%) of the preoperative total prostate volume (median 64.5 ml (range 40-80 ml)) was obtained for histological examination by aquablation. Due to severe mechanical destruction and fragmentation, only a proportion of 0.43% (0.06-1.79%) of this tissue represented histologically assessable glands. Therefore, roughly 0.017% of the total prostatic volume was available for a reliable histological examination. In comparison, 32.5% (6.67-37.5%) of the total prostate volume was removed by TURP and 22.86% (7.45-40.57%) of this tissue represented informative prostatic glands, corresponding to 7.43% of the total prostate volume.
CONCLUSION: Histological significance of the tissue obtained by aquablation of the prostate is very limited. Costs and effort of the histological examination must, therefore, be weighed critically against the limited informative value.

Entities:  

Keywords:  AquaBeam; Aquablation; Benign prostatic hyperplasia; Histology; Prostate; prostate tissue

Year:  2020        PMID: 32902728     DOI: 10.1007/s00345-020-03426-2

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  15 in total

1.  The significance of histological analysis following laser transurethral resection of the prostate.

Authors:  Shady Nafie; John Dormer; Masood A Khan
Journal:  Int Urol Nephrol       Date:  2017-05-15       Impact factor: 2.370

2.  Aquablation - image-guided robot-assisted waterjet ablation of the prostate: initial clinical experience.

Authors:  Peter Gilling; Rana Reuther; Arman Kahokehr; Mark Fraundorfer
Journal:  BJU Int       Date:  2015-11-19       Impact factor: 5.588

3.  WATER: A Double-Blind, Randomized, Controlled Trial of Aquablation® vs Transurethral Resection of the Prostate in Benign Prostatic Hyperplasia.

Authors:  Peter Gilling; Neil Barber; Mohamed Bidair; Paul Anderson; Mark Sutton; Tev Aho; Eugene Kramolowsky; Andrew Thomas; Barrett Cowan; Ronald P Kaufman; Andrew Trainer; Andrew Arther; Gopal Badlani; Mark Plante; Mihir Desai; Leo Doumanian; Alexis E Te; Mark DeGuenther; Claus Roehrborn
Journal:  J Urol       Date:  2018-01-31       Impact factor: 7.450

4.  Are Histological Findings of Thulium Laser Vapo-Enucleation Versus Transurethral Resection of the Prostate Comparable?

Authors:  Luca Carmignani; Alberto Macchi; Dario Ratti; Elisabetta Finkelberg; Stefano Casellato; Giorgio Bozzini; Serena Maruccia; Carlo Marenghi; Stefano Picozzi
Journal:  Pathol Oncol Res       Date:  2015-04-11       Impact factor: 3.201

Review 5.  Aquablation of the Prostate for Symptomatic Benign Prostatic Hyperplasia: Early Results.

Authors:  Omid Yassaie; Joshua A Silverman; Peter J Gilling
Journal:  Curr Urol Rep       Date:  2017-10-18       Impact factor: 3.092

6.  Aquablation of the Prostate for Symptomatic Benign Prostatic Hyperplasia: 1-Year Results.

Authors:  Peter Gilling; Paul Anderson; Andrew Tan
Journal:  J Urol       Date:  2017-01-20       Impact factor: 7.450

7.  Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline Amendment 2019.

Authors:  Harris E Foster; Philipp Dahm; Tobias S Kohler; Lori B Lerner; J Kellogg Parsons; Timothy J Wilt; Kevin T McVary
Journal:  J Urol       Date:  2019-08-08       Impact factor: 7.450

8.  Does laser ablation prostatectomy lead to oncological compromise?

Authors:  Suzanne M Biers; Helen C Oliver; Alex J King; Andrew S Adamson
Journal:  BJU Int       Date:  2008-09-08       Impact factor: 5.588

9.  WATER II (80-150 mL) procedural outcomes.

Authors:  Mihir Desai; Mo Bidair; Naeem Bhojani; Andrew Trainer; Andrew Arther; Eugene Kramolowsky; Leo Doumanian; Dean Elterman; Ronald P Kaufman; James Lingeman; Amy Krambeck; Gregg Eure; Gopal Badlani; Mark Plante; Edward Uchio; Greg Gin; Larry Goldenberg; Ryan Paterson; Alan So; Mitch Humphreys; Claus Roehrborn; Steven Kaplan; Jay Motola; Kevin C Zorn
Journal:  BJU Int       Date:  2018-06-10       Impact factor: 5.588

10.  Detection of prostate cancer by TURP or open surgery in patients with previously negative transrectal prostate biopsies.

Authors:  Richard Zigeuner; Luigi Schips; Katja Lipsky; Marko Auprich; Michael Salfellner; Peter Rehak; Karl Pummer; Gerhart Hubmer
Journal:  Urology       Date:  2003-11       Impact factor: 2.649

View more
  1 in total

1.  [Minimally invasive treatment options for the management of benign prostatic hyperplasia].

Authors:  J Franz; R Suarez-Ibarrola; D S Schoeb; C Gratzke; A Miernik
Journal:  Urologe A       Date:  2021-11-05       Impact factor: 0.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.